Last $2.96 USD
Change Today -0.05 / -1.66%
Volume 47.2K
ANTH On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 1:49 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - anthera pharmaceuticals inc (ANTH)

Name (Connections)Board RelationshipsTitleKey Developments
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 72 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
Daniel Spiegelman B.A., M.B.A. 68 RelationshipsDirector and Chairman of Audit Committee 

Compensation Committee* - anthera pharmaceuticals inc (ANTH)

Name (Connections)Board RelationshipsTitle
Bogdan Dziurzynski Ph.D., MBA, D.P.A. 33 RelationshipsDirector and Member of Compensation Committee
David Thompson 82 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
ANTH Compensation vs. Industry
507.9K
364.2K
Chief Executive Officer
Share price activity for ANTHERA PHARMACEUTICALS INC (ANTH)
52 Week Price Performance
ANTH
Industry Average

Nominating Committee* - anthera pharmaceuticals inc (ANTH)

Name (Connections)Board RelationshipsTitleKey Developments
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 72 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeAnthera Pharmaceuticals, Inc. Announces Board Changes
03/31/14
David Thompson 82 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeAnthera Pharmaceuticals Announces Board Changes
03/31/14
Steven Engle 68 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeAnthera Pharmaceuticals, Inc. Announces Executive Changes
06/12/13

Corporate Governance Committee* - anthera pharmaceuticals inc (ANTH)

Name (Connections)Board RelationshipsTitle
Steven Engle 68 RelationshipsDirector and Member of Compensation Committee
Christopher Henney B.Sc. (Hons.), Ph.D., D.Sc. 72 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
David Thompson 82 Relationships--
ANTH and Competitor
Insiders vs. External
Board
4%
96%
Anthera Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - anthera pharmaceuticals inc (ANTH)

Name (Board Relationships)/Title Board Affiliations
Jonathan Barratt 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
Robert Fishman 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
David Isenberg 32 Relationships
Member of Scientific Advisory Board
No other board affiliations
Kenneth Kalunian 32 Relationships
Member of Scientific Advisory Board
No other board affiliations
Alan Leff 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
Adrian Liew 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
Liz Lightstone 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
Michael Matthay 51 Relationships
Member of Scientific Advisory Board
No other board affiliations
Sandra Navarra 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Nicholls 41 Relationships
Member of Scientific Advisory Board
No other board affiliations
Daniel Odenheimer 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Rennard 50 Relationships
Member of Scientific Advisory Board
No other board affiliations
Robert Rosenson 48 Relationships
Member of Scientific Advisory Board
No other board affiliations
Mao Chan Tak 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
B. Thompson 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
David Waters 33 Relationships
Member of Scientific Advisory Board
No other board affiliations
David Wofsy 23 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANTH:US $2.96 USD -0.05

ANTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANTH.
View Industry Companies
 

Industry Analysis

ANTH

Industry Average

Valuation ANTH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTHERA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.